Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Pharmacology/Therapy

Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA-targeted radioligand therapy

The Prostate | Oct 15, 2021 Pharmacology/Therapy

A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients

Journal of the American Academy of Dermatology | Oct 14, 2021 Pharmacology/Therapy

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): A randomised, multicentre, open-label, phase 3 trial

The Lancet | Oct 13, 2021 Pharmacology/Therapy

Fulvestrant-palbociclib vs letrozole-palbociclib as initial therapy for advanced breast cancer

JAMA | Oct 13, 2021 Pharmacology/Therapy

Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: Analysis of the JPLT3-H pilot study

Pediatric Blood & Cancer | Oct 13, 2021 Pharmacology/Therapy

Enzalutamide vs bicalutamide in patients with nonmetastatic castration- resistant prostate cancer: A prespecified subgroup analysis of the STRIVE trial

Prostate Cancer & Prostatic Diseases | Oct 12, 2021 Pharmacology/Therapy

Survival analysis of stage II gastric cancer patients after D2 gastrectomy: A Chinese people-based research

BMC Gastroenterology | Oct 12, 2021 Pharmacology/Therapy

An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer

Gynecologic Oncology | Oct 10, 2021 Pharmacology/Therapy

Diagnosis and management of melanoma of the scalp: A review of the literature

Clinical, Cosmetic and Investigational Dermatology | Oct 10, 2021 Pharmacology/Therapy

The immunomodulatory activity of lenvatinib prompts the survival of patients with advanced hepatocellular carcinoma

Cancer Medicine | Oct 08, 2021 Pharmacology/Therapy

« Prev 1 … 12 13 14 15 16 … 375 Next »

Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA-targeted radioligand therapy

A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): A randomised, multicentre, open-label, phase 3 trial

Fulvestrant-palbociclib vs letrozole-palbociclib as initial therapy for advanced breast cancer

Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: Analysis of the JPLT3-H pilot study

Enzalutamide vs bicalutamide in patients with nonmetastatic castration- resistant prostate cancer: A prespecified subgroup analysis of the STRIVE trial

Survival analysis of stage II gastric cancer patients after D2 gastrectomy: A Chinese people-based research

An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer

Diagnosis and management of melanoma of the scalp: A review of the literature

The immunomodulatory activity of lenvatinib prompts the survival of patients with advanced hepatocellular carcinoma

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Breast-Conserving Surgery in Cancer Patients

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Article on Hypertension in CKD Patients: Management Updates

Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA-targeted radioligand therapy

A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): A randomised, multicentre, open-label, phase 3 trial

Fulvestrant-palbociclib vs letrozole-palbociclib as initial therapy for advanced breast cancer

Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: Analysis of the JPLT3-H pilot study

Enzalutamide vs bicalutamide in patients with nonmetastatic castration- resistant prostate cancer: A prespecified subgroup analysis of the STRIVE trial

Survival analysis of stage II gastric cancer patients after D2 gastrectomy: A Chinese people-based research

An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer

Diagnosis and management of melanoma of the scalp: A review of the literature

The immunomodulatory activity of lenvatinib prompts the survival of patients with advanced hepatocellular carcinoma

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Breast-Conserving Surgery in Cancer Patients

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Article on Hypertension in CKD Patients: Management Updates

Select Specialty

Select Topic